Search research articles
Contact Us
Filters
Showing results (371-380 of 795) with videos related to
Page
of 80
Sort By:
Journal of Autoimmunity
|
July 30, 2013
The autoimmune disease-associated SNP rs917997 of IL18RAP controls IFNγ production by PBMC
Courtney B Myhr, Maigan A Hulme, Clive H Wasserfall, et al.
ACS Synthetic Biology
|
May 24, 2024
Programming Probiotics: Diet-Responsive Gene Expression and Colonization Control in Engineered <i>S. boulardii</i>
Deniz Durmusoglu, Daniel J Haller, Ibrahim S Al'Abri, et al.
JAMA
|
November 9, 1994
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group
J M Seddon, U A Ajani, R D Sperduto, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
January 21, 2023
Project ECHO Diabetes Cost Modeling to Support the Replication and Expansion of Tele-mentoring Programs in Non-research Settings
Eugene M Lewit, Lauren E Figg, Ananta Addala, et al.
Annals of the New York Academy of Sciences
|
January 6, 2009
Exendin-4 therapy in NOD mice with new-onset diabetes increases regulatory T cell frequency
Song Xue, Clive H Wasserfall, Matthew Parker, et al.
The New England Journal of Medicine
|
November 18, 2020
Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes
Teresa Quattrin, Michael J Haller, Andrea K Steck, et al.
BMJ Open
|
August 30, 2023
Recruiting historically under-represented individuals into Project ECHO Diabetes: using barrier analysis to understand disparities in clinical research in the USA
Ananta Addala, Melanie Hechavarria, Lauren Figg, et al.
Ophthalmology
|
May 21, 1998
Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study
R D Sperduto, R Hiller, E Chew, et al.
Diabetes, Obesity & Metabolism
|
May 27, 2026
A Phase 2 Trial of Frexalimab, a CD40L Antagonist, in Adolescents and Adults With Recent-Onset Type 1 Diabetes (FABULINUS): Rationale and Study Design
Andriy Cherkas, Baerbel Rotthaeuser, Niels Porksen, et al.
Diabetes
|
May 23, 2020
Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials
Jay M Sosenko, Jay S Skyler, Kevan C Herold, et al.
Page
of 80
Search research articles
Search
Showing results (371-380 of 795) with videos related to
Sort By:
Page
of 80
Journal of Autoimmunity
|
July 30, 2013
The autoimmune disease-associated SNP rs917997 of IL18RAP controls IFNγ production by PBMC
Courtney B Myhr, Maigan A Hulme, Clive H Wasserfall, et al.
ACS Synthetic Biology
|
May 24, 2024
Programming Probiotics: Diet-Responsive Gene Expression and Colonization Control in Engineered <i>S. boulardii</i>
Deniz Durmusoglu, Daniel J Haller, Ibrahim S Al'Abri, et al.
JAMA
|
November 9, 1994
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group
J M Seddon, U A Ajani, R D Sperduto, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
January 21, 2023
Project ECHO Diabetes Cost Modeling to Support the Replication and Expansion of Tele-mentoring Programs in Non-research Settings
Eugene M Lewit, Lauren E Figg, Ananta Addala, et al.
Annals of the New York Academy of Sciences
|
January 6, 2009
Exendin-4 therapy in NOD mice with new-onset diabetes increases regulatory T cell frequency
Song Xue, Clive H Wasserfall, Matthew Parker, et al.
The New England Journal of Medicine
|
November 18, 2020
Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes
Teresa Quattrin, Michael J Haller, Andrea K Steck, et al.
BMJ Open
|
August 30, 2023
Recruiting historically under-represented individuals into Project ECHO Diabetes: using barrier analysis to understand disparities in clinical research in the USA
Ananta Addala, Melanie Hechavarria, Lauren Figg, et al.
Ophthalmology
|
May 21, 1998
Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study
R D Sperduto, R Hiller, E Chew, et al.
Diabetes, Obesity & Metabolism
|
May 27, 2026
A Phase 2 Trial of Frexalimab, a CD40L Antagonist, in Adolescents and Adults With Recent-Onset Type 1 Diabetes (FABULINUS): Rationale and Study Design
Andriy Cherkas, Baerbel Rotthaeuser, Niels Porksen, et al.
Diabetes
|
May 23, 2020
Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials
Jay M Sosenko, Jay S Skyler, Kevan C Herold, et al.
Page
of 80